Top list · Europe
213 pharma startups in Europe have raised money in rounds we track. These are the 50 that have raised the most, $6.8B between them, with the United Kingdom the most common home.
ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.
Founded 2011Lausanne, Switzerland$646Mlast round Oct 2026CellCentric is a clinical-stage biopharmaceutical company based in Cambridge, UK.
Founded 2004Saffron Walden, United Kingdom$525Mlast round May 2026OMass Therapeutics is a biotechnology company located in Oxford, UK, focused on discovering and developing novel small molecule medicines for rare diseases and
Founded 2016Oxford, United Kingdom$442Mlast round Oct 2026Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology.
Founded -London, United Kingdom$350Mlast round Feb 2024NPM is all about bringing the best and most innovative chemistry to their product discovery projects and collaborations.
Founded 2015United Kingdom$346Mlast round Aug 2025Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.
Founded 2015Cambridge, United Kingdom$276Mlast round Jan 2025GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.
Founded 2018Dublin, Ireland$268Mlast round Apr 2026Draig Therapeutics is a clinical-stage biotechnology company based in Cardiff, Wales, focused on developing innovative neuropsychiatric therapies.
Founded 2021Cardiff, United Kingdom$216Mlast round Jul 2026Adcendo ApS is a clinical-stage biotechnology company based in Frederiksberg, Copenhagen, Denmark, with operational offices in Boston, Massachusetts.
Founded 2017Frederiksberg, Denmark$210Mlast round Apr 2026Alfasigma is a pharmaceutical company that has accepted an important challenge.
Founded 2015Bologna, Italy$176Mlast round Jul 2025Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
Founded 2017London, United Kingdom$159Mlast round May 2026Quercis Pharma is a biopharmaceutical company that brings innovative and safe medicine to patients with orphan diseases.
Founded 2019Zug, Switzerland$150Mlast round Dec 2021Artios Pharma is a independent DNA Damage Response company with a strong pipeline of novel cancer therapies.
Founded 2016Cambridge, United Kingdom$148Mlast round Nov 2025Freeline Therapeutics specializes in CMC process development, analytics and AAV technologies.
Founded 2015Stevenage, United Kingdom$142Mlast round Mar 2022Innovative and disruptive skin-care products based on biotech.
Founded 2014United Kingdom$133Mlast round Sept 2026GlycoEra is a CustomGlycanengineering platform that unlocks the glycan-mediated biology to develop a pipeline of novel therapeutics.
Founded 2020Schlieren, Switzerland$130Mlast round May 2025Amryt Pharma creates and delivers innovative treatments to help patients with rare and orphan diseases live better lives.
Founded -Dublin, Ireland$125Mlast round Feb 2022Inventiva Pharma is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.
Founded 2011Daix, France$120Mlast round Jun 2026Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines.
Founded 1998Søborg (Copenhagen), Denmark$100Mlast round Aug 2026Archimedes Pharma is a specialty pharmaceutical company developing therapeutics for the treatment of chronic and debilitating illnesses.
Founded 2004Reading, United Kingdom$99Mlast round Apr 2010Ona Therapeutics is a clinical-stage biotechnology company based in the Barcelona Science Park, Spain.
Founded 2019Barcelona, Spain$98Mlast round Jun 2026ImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules.
Founded 2015Marseille, France$97Mlast round Aug 202421st.BIO is a biotechnology company based in Copenhagen, Denmark, founded in 2020.
Founded 2020Soborg, Denmark$97Mlast round Dec 2021Vivet Therapeutics is a biotechnology company developing gene therapy treatments for orphan diseases.
Founded 2016Paris, France$96Mlast round Feb 2024Genomics Ltd, founded in 2014 in Oxford, UK, is a global techbio and precision medicine company.
Founded 2014Oxford, United Kingdom$93Mlast round Jan 2024Mereo is a new UK-based speciality biopharmaceutical company.
Founded 2015London, United Kingdom$92Mlast round Feb 2025Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.
Founded 2016Hanover, Germany$92Mlast round Aug 2021AnaCardio is a clinical-stage biopharmaceutical company based in Solna, Sweden, focused on developing innovative treatments for heart failure.
Founded 2017Gothenburg, Switzerland$89Mlast round Oct 2026Augustine Therapeutics is a Belgian biotechnology company founded in 2019 and based in Leuven.
Founded 2019Leuven, Belgium$84Mlast round Mar 2025NRG Therapeutics Ltd is a private biotechnology company focused on drug discovery for neurodegenerative disorders.
Founded 2018Stevenage, United Kingdom$79Mlast round Sept 2025Constructive Bio is a biotechnology company based in Cambridge, UK, founded in 2021 as a spin-out from Professor Jason Chin’s laboratory.
Founded 2021Whittlesford, United Kingdom$73Mlast round Apr 2025Naturmet develops and operates biomethane production plants in Spain.
Founded -Álava, Spain$69Mlast round Jun 2026Abzena is a biotechnology company that offers biologic and ADC products from concept to clinic.
Founded 2001San Diego, United Kingdom$65Mlast round Nov 2015Neurosterix is a Geneva-based biopharmaceutical company founded in 2024, specializing in the development of next-generation allosteric modulators for neurologic
Founded 2024Geneva, Switzerland$63Mlast round Apr 2024Enterome SA is a clinical-stage biopharmaceutical company based in Paris, France, with operations in Évry.
Founded 2011Paris, France$58Mlast round Jun 2025Duke Street Bio is a biotechnology research company based in London, England, founded in 2020.
Founded 2020London, United Kingdom$55Mlast round Apr 2026Canton Strategic Holdings drives institutional blockchain adoption via the Canton Network, digital assets, and market digitization.
Founded -Chester, United Kingdom$55Mlast round Jan 2026EUSA Pharma is a pharmaceutical company developing and licensing late-stage oncology, pain control, and critical care products.
Founded 2006Hemel Hempstead, United Kingdom$54Mlast round Jun 2007ENYO Pharma is a clinical-stage biopharmaceutical company based in Lyon, France.
Founded 2014Lyon, France$54Mlast round Jun 2025AAA is an innovative medicines company focused on the development of targeted radioligand therapies and precision imaging radioligands.
Founded 2002Saint Genis Pouilly, France$53Mlast round Feb 2014ViaNautis, founded in 2018 as a spin-off from University College London, is a biotechnology company based in Cambridge, United Kingdom.
Founded 2018Cambridge, United Kingdom$52Mlast round Sept 2026Cimeio Therapeutics is a biotechnology and drug discovery company founded in 2020, with dual headquarters in Cambridge, MA, USA, and Basel, Switzerland.
Founded 2020Cambridge, Switzerland$50Mlast round Apr 2022Full-Life Technologies is a global radiotherapeutics company founded in 2021 and headquartered in Shanghai, China, with operations in Belgium, Germany, and the
Founded 2021Gembloux, Belgium$50Mlast round Sept 2025Enara Bio Limited, based in Oxford, United Kingdom, is a biotechnology company focused on developing innovative cancer immunotherapies.
Founded 2016Oxford, United Kingdom$49Mlast round Oct 2024Biolevate is a health-tech startup based in Sucy-en-Brie, near Paris, founded in 2023.
Founded 2024Paris, France$41Mlast round Sept 2026Astrophysics technology for precision therapy through accurate modelling of biology
Founded 2018London, United Kingdom$41Mlast round Mar 2025Antisense Pharma is a company based out of Germany.
Founded 1998Regensburg, Germany$40Mlast round Jan 2012NVision Imaging Technologies develops Quantum MRI agents for assessing early patient response to treatment at the metabolic level.
Founded 2015Ulm, Germany$40Mlast round May 2026Companies whose funding rounds we classed as this sector, ranked by the total they have raised in rounds we hold. Nobody pays to be on a list.
Open any company for its rounds and investors, or search the investors who back pharma startups in Europe in the app, with filters, lists and exports.
ILO
NHHealth startups in Europe3,025 companies · $29B
IL
NH
CSBiotech startups in Europe1,665 companies · $22B
NGBig data startups in Europe964 companies · $31B
V
S
CGEnergy providers startups in Europe953 companies · $41B
S
EP
SClimate tech startups in Europe756 companies · $25B
SK
FCFintech startups in Europe749 companies · $30B
A
CI
YCustomer service startups in Europe720 companies · $13BN
W
TTransport startups in Europe697 companies · $28B